Observational study on outcomes of advanced pelvic cancer surgeries

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study focuses on patients undergoing advanced pelvic oncological resections for malignancies, including multi-visceral resections and reconstructive procedures. Conducted at Glasgow Royal Infirmary, it aims to collect and analyze data on patient outcomes, major complications, and the natural history of those undergoing such complex surgeries. The findings will help identify areas for future interventional studies to improve patient care.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Advanced pelvic oncological resection defined as more than 1 pelvic organ resected

Exclusion Criteria:

\-

Where it's running

• Academic Department of Surgery, Glasgow Royal Infirmary
  Glasgow, United Kingdom Recruiting

Study contacts

• Study coordinator: Norman Galbraith, PhD MRCS
• Email: norman.galbraith@glasgow.ac.uk
• Phone: 07449784948

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Using brodalumab to treat immune-related side effects from cancer therapy

  This study is testing if brodalumab can help cancer patients who are having immune-related side effects from their immunotherapy treatment feel better.

  Recruiting Phase 1 Columbia University · New York, New York · NCT06673329

• DEM301 in advanced colorectal cancer: a first-in-human test

  This first-in-human Phase 1 study tests DEM301 in adults with advanced metastatic colorectal cancer to see if it is safe, how it behaves in the body, and whether it shows any signs of activity.

  Recruiting at 2 sites Phase 1 DEM BioPharma, Inc. · Birtinya, Queensland and 1 other locations · NCT07805369

• Quality of life after colorectal cancer treatment

  This project will test whether late side effects at 6, 12, and 24 months affect quality of life in people aged 25–65 who completed initial treatment for colorectal cancer at the Institute of Oncology Ljubljana.

  Recruiting Institute of Oncology Ljubljana · Ljubljana · NCT07427901

• CEA-targeted CAR-T for advanced CEA-positive solid tumors

  This trial will try CEA-targeted CAR-T cell infusions in adults with advanced CEA-positive cancers (such as colorectal, gastric, esophageal, lung, or pancreatic cancer) to see if the treatment is safe and helps control the disease.

  Recruiting Phase 1 Chongqing Precision Biotech Co., Ltd · Hefei, Anhui · NCT07179692

• Health-Oriented Protocol for Epidermal Radiodermatitis

  This study looks at how skin reactions from radiation therapy affect adults with head/neck or pelvic cancers and whether certain factors influence RID outcomes.

  Recruiting Fondazione Policlinico Universitario Agostino Gemelli IRCCS · Roma, RM · NCT07129525

• Preserving the superior left colic artery to improve blood flow to the descending colon before reconnecting the bowel after left-sided, rectal, or ovarian cancer surgery

  This trial will test in adults having left colon, rectal, or ovarian cancer surgery whether preserving the superior left colic artery and temporarily managing the inferior mesenteric artery improves blood flow to the descending colon and reduces healing problems after the bowel is reconnected.

  Recruiting Institut du Cancer de Montpellier - Val d'Aurelle · Montpellier, Herault · NCT07098182

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.